<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vocal fold immobility &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/vocal-fold-immobility/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Wed, 27 May 2026 13:12:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Vocal fold immobility &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study on the Effectiveness of Autologous Adipose-Derived Stromal Vascular Fraction Cells for Patients with Scarred Vocal Folds</title>
		<link>https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-autologous-adipose-derived-stromal-vascular-fraction-cells-for-patients-with-scarred-vocal-folds/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 14:58:52 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-autologous-adipose-derived-stromal-vascular-fraction-cells-for-patients-with-scarred-vocal-folds/</guid>

					<description><![CDATA[This clinical trial is focused on the treatment of scarred vocal cords, a condition that can affect the voice, making it difficult to speak clearly. The study is testing a new treatment using autologous adipose tissue-derived stromal vascular fraction cells. These are special cells taken from a person&#8217;s own fat tissue, which are then injected [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on the treatment of <b>scarred vocal cords</b>, a condition that can affect the voice, making it difficult to speak clearly. The study is testing a new treatment using <b>autologous adipose tissue-derived stromal vascular fraction cells</b>. These are special cells taken from a person&#8217;s own fat tissue, which are then injected into the vocal cords. The aim is to see if this treatment can improve the voice by reducing the scarring.</p>
<p>Participants in the study will receive either the new cell treatment or a <b>placebo</b>, which is a solution containing <b>sodium chloride</b> and <b>human serum albumin</b> but no active cells. The purpose of the study is to compare the effectiveness of the cell treatment against the placebo in improving voice quality. This will be measured using a tool called the Voice Handicap Index, which helps assess how much the voice problem affects daily life. The study will look for improvements in voice quality six months after the treatment.</p>
<p>Throughout the study, participants will undergo various assessments to monitor changes in their voice. These assessments include self-evaluations, voice measurements, and video examinations of the vocal cords. The study will also track any side effects that may occur. The goal is to determine if the new treatment can provide a significant improvement in voice quality for those with scarred vocal cords.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
